MY136840A - Pyrazolopyridines as cyclin dependent kinase inhibitors - Google Patents
Pyrazolopyridines as cyclin dependent kinase inhibitorsInfo
- Publication number
- MY136840A MY136840A MYPI20033535A MYPI20033535A MY136840A MY 136840 A MY136840 A MY 136840A MY PI20033535 A MYPI20033535 A MY PI20033535A MY PI20033535 A MYPI20033535 A MY PI20033535A MY 136840 A MY136840 A MY 136840A
- Authority
- MY
- Malaysia
- Prior art keywords
- compounds
- cyclin dependent
- pyrazolopyridines
- kinase inhibitors
- dependent kinase
- Prior art date
Links
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 title 1
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 title 1
- 150000005229 pyrazolopyridines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 108091007914 CDKs Proteins 0.000 abstract 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 abstract 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- DVUBDHRTVYLIPA-UHFFFAOYSA-N pyrazolo[1,5-a]pyridine Chemical class C1=CC=CN2N=CC=C21 DVUBDHRTVYLIPA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41213802P | 2002-09-19 | 2002-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY136840A true MY136840A (en) | 2008-11-28 |
Family
ID=32030811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20033535A MY136840A (en) | 2002-09-19 | 2003-09-17 | Pyrazolopyridines as cyclin dependent kinase inhibitors |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7151104B2 (enExample) |
| EP (1) | EP1539750B1 (enExample) |
| JP (1) | JP4845380B2 (enExample) |
| KR (1) | KR20050072090A (enExample) |
| CN (1) | CN100475812C (enExample) |
| AR (1) | AR041292A1 (enExample) |
| AT (1) | ATE382048T1 (enExample) |
| AU (1) | AU2003270846B2 (enExample) |
| CA (1) | CA2499593C (enExample) |
| DE (1) | DE60318321T2 (enExample) |
| ES (1) | ES2297203T3 (enExample) |
| IL (1) | IL167432A (enExample) |
| MX (1) | MXPA05003059A (enExample) |
| MY (1) | MY136840A (enExample) |
| NZ (1) | NZ538595A (enExample) |
| TW (1) | TWI283243B (enExample) |
| WO (1) | WO2004026872A1 (enExample) |
| ZA (1) | ZA200502271B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2273083C (en) * | 1996-12-03 | 2012-09-18 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US20020058286A1 (en) * | 1999-02-24 | 2002-05-16 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto and analogues thereof |
| DK1767535T3 (da) | 2002-08-23 | 2010-04-12 | Sloan Kettering Inst Cancer | Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse |
| US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| ES2403558T3 (es) * | 2004-08-27 | 2013-05-20 | Cyclacel Limited | Inhibidores purínicos y pirimidínicos de CDK y su uso para el tratamiento de enfermedades autoinmunitarias |
| KR20070108270A (ko) * | 2005-02-28 | 2007-11-08 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 술폰아미드 화합물의 신규 병용 |
| WO2006090931A1 (ja) * | 2005-02-28 | 2006-08-31 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物の抗癌剤との新規併用 |
| US7304074B2 (en) | 2005-04-05 | 2007-12-04 | Hoffmann-La Roche Inc. | Substituted 1,5-naphthyridine azolinones |
| WO2006109867A1 (ja) * | 2005-04-07 | 2006-10-19 | Teijin Pharma Limited | ピラゾロ［１，５-ａ］ピリジン誘導体またはその医学上許容される塩 |
| US7417053B2 (en) | 2005-04-07 | 2008-08-26 | Teijin Pharma Limited | Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
| WO2007032936A2 (en) | 2005-09-09 | 2007-03-22 | Schering Corporation | Azafused cyclin dependent kinase inhibitors |
| WO2008066789A2 (en) * | 2006-11-27 | 2008-06-05 | H. Lundbeck A/S | Heteroaryl amide derivatives |
| KR20090031122A (ko) * | 2007-09-21 | 2009-03-25 | 주식회사 중외제약 | 인다졸 골격을 함유하는 화합물, 이의 제조방법 및 상기화합물을 함유하는 약제학적 조성물 |
| FR2940284B1 (fr) * | 2008-12-19 | 2011-02-18 | Sanofi Aventis | Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique |
| UY34305A (es) | 2011-09-01 | 2013-04-30 | Novartis Ag | Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar |
| US9073921B2 (en) | 2013-03-01 | 2015-07-07 | Novartis Ag | Salt forms of bicyclic heterocyclic derivatives |
| WO2016160617A2 (en) * | 2015-03-27 | 2016-10-06 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| WO2017087409A1 (en) | 2015-11-18 | 2017-05-26 | Genzyme Corporation | Biomarker of polycystic kidney disease and uses thereof |
| MX390117B (es) * | 2016-09-07 | 2025-03-20 | Haihe Biopharma Co Ltd | Compuesto de anillo aromatico de pirido de cinco elementos, metodo de preparacion y uso del mismo. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69627195T2 (de) | 1995-11-01 | 2004-01-29 | Novartis Ag | Purinderivate und verfahren zu ihrer herstellung |
| EP1043998B1 (en) | 1997-12-13 | 2007-03-07 | Bristol-Myers Squibb Company | USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDANT KINASE INHIBITORS |
| SE9802794D0 (sv) * | 1998-08-21 | 1998-08-21 | Astra Ab | New compounds |
| FR2801308B1 (fr) * | 1999-11-19 | 2003-05-09 | Oreal | COMPOSITIONS DE TEINTURE DE FIBRES KERATINIQUES CONTENANT DE DES 3-AMINO PYRAZOLO-[1,(-a]-PYRIDINES, PROCEDE DE TEINTURE, NOUVELLES 3-AMINO PYRAZOLO-[1,5-a]-PYRIDINES |
| WO2001056607A1 (en) * | 2000-02-03 | 2001-08-09 | Eisai Co., Ltd. | Integrin expression inhibitors |
| AU2002225096B8 (en) * | 2000-12-20 | 2006-07-27 | Ipsen Pharma S.A.S. | Cyclin-dependent kinase (CDK) and glycogen synthase kinase-3 (GSK-3) inhibitors |
| IL157461A0 (en) * | 2001-03-08 | 2004-03-28 | Astrazeneca Ab Astrazeneca Ab | Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer |
| CN1202896C (zh) * | 2002-02-07 | 2005-05-25 | 北京燕化高新技术股份有限公司 | 空气分离时纯化空气的方法 |
-
2003
- 2003-09-17 JP JP2004538405A patent/JP4845380B2/ja not_active Expired - Fee Related
- 2003-09-17 KR KR1020057004435A patent/KR20050072090A/ko not_active Abandoned
- 2003-09-17 AU AU2003270846A patent/AU2003270846B2/en not_active Ceased
- 2003-09-17 EP EP03752559A patent/EP1539750B1/en not_active Expired - Lifetime
- 2003-09-17 AR ARP030103374A patent/AR041292A1/es active IP Right Grant
- 2003-09-17 MX MXPA05003059A patent/MXPA05003059A/es active IP Right Grant
- 2003-09-17 MY MYPI20033535A patent/MY136840A/en unknown
- 2003-09-17 TW TW092125613A patent/TWI283243B/zh not_active IP Right Cessation
- 2003-09-17 CA CA2499593A patent/CA2499593C/en not_active Expired - Fee Related
- 2003-09-17 DE DE60318321T patent/DE60318321T2/de not_active Expired - Lifetime
- 2003-09-17 ES ES03752559T patent/ES2297203T3/es not_active Expired - Lifetime
- 2003-09-17 NZ NZ538595A patent/NZ538595A/en not_active IP Right Cessation
- 2003-09-17 US US10/664,337 patent/US7151104B2/en not_active Expired - Lifetime
- 2003-09-17 WO PCT/US2003/029841 patent/WO2004026872A1/en not_active Ceased
- 2003-09-17 AT AT03752559T patent/ATE382048T1/de not_active IP Right Cessation
- 2003-09-17 CN CNB038220113A patent/CN100475812C/zh not_active Expired - Fee Related
-
2005
- 2005-03-15 IL IL167432A patent/IL167432A/en not_active IP Right Cessation
- 2005-03-17 ZA ZA200502271A patent/ZA200502271B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ538595A (en) | 2006-04-28 |
| AR041292A1 (es) | 2005-05-11 |
| ATE382048T1 (de) | 2008-01-15 |
| EP1539750B1 (en) | 2007-12-26 |
| CN100475812C (zh) | 2009-04-08 |
| ZA200502271B (en) | 2005-09-19 |
| TW200409775A (en) | 2004-06-16 |
| CN1681816A (zh) | 2005-10-12 |
| JP4845380B2 (ja) | 2011-12-28 |
| IL167432A (en) | 2010-05-17 |
| EP1539750A1 (en) | 2005-06-15 |
| WO2004026872A1 (en) | 2004-04-01 |
| JP2006503060A (ja) | 2006-01-26 |
| AU2003270846A1 (en) | 2004-04-08 |
| US7151104B2 (en) | 2006-12-19 |
| TWI283243B (en) | 2007-07-01 |
| CA2499593C (en) | 2011-08-16 |
| DE60318321T2 (de) | 2008-12-11 |
| HK1071758A1 (en) | 2005-07-29 |
| AU2003270846B2 (en) | 2006-11-23 |
| KR20050072090A (ko) | 2005-07-08 |
| US20040097516A1 (en) | 2004-05-20 |
| MXPA05003059A (es) | 2005-05-27 |
| ES2297203T3 (es) | 2008-05-01 |
| CA2499593A1 (en) | 2004-04-01 |
| DE60318321D1 (en) | 2008-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY133311A (en) | Novel imidazopyridines as cyclin dependent kinase inhibitors | |
| MY134589A (en) | Imidazopyrazines as cyclin dependent kinase inhibitors | |
| MY139336A (en) | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| MY137888A (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| MY145332A (en) | Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| MY149044A (en) | Pyrazolopyrimidines - derivatives as cyclin dependent kinase inhibitors | |
| WO2004026310A8 (en) | Novel imidazopyrazines as cyclin dependent kinase inhibitors | |
| NO20051647L (no) | Pyrazolopyrimidiner som syklinavhengige kinaseinhibitorer | |
| WO2007044449A3 (en) | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| MX2009003733A (es) | Pirazolopirimidinas como inhibidores de quinasas dependientes de ciclina. | |
| MX2009011355A (es) | Nuevas pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas. | |
| TW200745123A (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
| WO2007044401A3 (en) | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| WO2007058873A3 (en) | Imidazopyrazines as cyclin depentend kinase inhibitors | |
| MX2009003734A (es) | Pirazolopirimidinas como inhibidor de cinasas dependientes de ciclina. | |
| WO2008045267A3 (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| TW200745128A (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
| MY136840A (en) | Pyrazolopyridines as cyclin dependent kinase inhibitors | |
| DE602006014848D1 (de) | Pyrazolopyrimidine als inhibitoren von cyclinabhän | |
| TW200745127A (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
| MX2009005011A (es) | Imidazopirazinas como inhibidores de proteina quinasa. | |
| WO2007032936A3 (en) | Azafused cyclin dependent kinase inhibitors | |
| ECSP11005642A (es) | Nuevos pirazolopirimidinas como inhibidores de quinasa dependientes de ciclinas | |
| ECSP066763A (es) | Pirazolopirimidinas novedosas como inhibidores de quinasa ciclina-dependientes | |
| WO2003063764A3 (en) | 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS |